Document
IPR2015-01980, No. 1028 Exhibit - AMNEAL 1028 McBride, INT L J MS CARE 4 85 2002 (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1028 Exhibit - AMNEAL 1028 McBride, INT L J MS CARE 4 85 2002 (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1011 Exhibit - AMNEAL 1011 Christina Caon et al, Randomized, Prospective, Rater Blinded, Four Year Pilot Study to Compare the Effect of Daily Versus Every Other Day Gl...
Cite Document
IPR2015-01980, No. 1011 Exhibit - AMNEAL 1011 Christina Caon et al, Randomized, Prospective, Rater Blinded, Four Year Pilot Study to Compare the Effect of Daily Versus Every Other Day Glatiramer Aceta
+ More Snippets
Document
IPR2015-01980, No. 1045 Exhibit - AMNEAL 1045 Tjalf Ziemssen et al, Effects of glatiramer acetate on fatigue and days of absence from work in first time treated relapsing remitting multiple scle...
Cite Document
IPR2015-01980, No. 1045 Exhibit - AMNEAL 1045 Tjalf Ziemssen et al, Effects of glatiramer acetate on fatigue and days of absence from work in first time treated relapsing remitting multiple sclerosis
+ More Snippets
Document
IPR2015-01980, No. 1029 Exhibit - AMNEAL 1029 Dene Simpson, Adis Drug Evaluation Glatiramer Acetate A Review of its use in Relapsing Remitting Multiple Sclerosis (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1029 Exhibit - AMNEAL 1029 Dene Simpson, Adis Drug Evaluation Glatiramer Acetate A Review of its use in Relapsing Remitting Multiple Sclerosis (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1030 Exhibit - AMNEAL 1030 Catherine M Edgar, et al, Lipoatrophy in Patients with Multiple Sclerosis on Glatiramer Acetate (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1030 Exhibit - AMNEAL 1030 Catherine M Edgar, et al, Lipoatrophy in Patients with Multiple Sclerosis on Glatiramer Acetate (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1038 Exhibit - AMNEAL 1038 CC Ford et al, A prospective open label study of glatiramer acetate over a decade of continuous use in multiple sclerosis patients (P.T.A.B. Sep...
Cite Document
IPR2015-01980, No. 1038 Exhibit - AMNEAL 1038 CC Ford et al, A prospective open label study of glatiramer acetate over a decade of continuous use in multiple sclerosis patients (P.T.A.B. Sep. 25, 201
+ More Snippets
Document
IPR2015-01980, No. 1014 Exhibit - AMNEAL 1014 MB Bornstein, Multiple Sclerosis Trial of a Synthetic Polypeptide (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1014 Exhibit - AMNEAL 1014 MB Bornstein, Multiple Sclerosis Trial of a Synthetic Polypeptide (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1034 Exhibit - AMNEAL 1034 Paul Beringer et al, Clinical Pharmacokinetics and Pharmacodynamics, in REMINGTON (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1034 Exhibit - AMNEAL 1034 Paul Beringer et al, Clinical Pharmacokinetics and Pharmacodynamics, in REMINGTON (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1053 Exhibit - AMNEAL 1053 Extavia Product Label 2009 (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1053 Exhibit - AMNEAL 1053 Extavia Product Label 2009 (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1024 Exhibit - AMNEAL 1024 US Patent No 6,342,476 (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1024 Exhibit - AMNEAL 1024 US Patent No 6,342,476 (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1013 Exhibit - AMNEAL 1013 James R Miller, The importance of early diagnosis of multiple sclerosis (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1013 Exhibit - AMNEAL 1013 James R Miller, The importance of early diagnosis of multiple sclerosis (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1054 Exhibit - AMNEAL 1054 Jacobs et al, Intramuscular interferon beta 1a therapy initiated during a first demyelinating event in multiple sclerosis (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1054 Exhibit - AMNEAL 1054 Jacobs et al, Intramuscular interferon beta 1a therapy initiated during a first demyelinating event in multiple sclerosis (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1039 Exhibit - AMNEAL 1039 Frohman, Multiple Sclerosis The Plaque and its Pathogenesis (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1039 Exhibit - AMNEAL 1039 Frohman, Multiple Sclerosis The Plaque and its Pathogenesis (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-01980, No. 1041 Exhibit - AMNEAL 1041 Peter J Manso et al, Life cycle management of ageing pharmaceutical assets (P.T.A.B. Sep. 25, 2015)
Cite Document
IPR2015-01980, No. 1041 Exhibit - AMNEAL 1041 Peter J Manso et al, Life cycle management of ageing pharmaceutical assets (P.T.A.B. Sep. 25, 2015)
+ More Snippets
Document
IPR2015-00644, No. 1099-2 Exhibit - Declaration of Prof Joel Hay Public Version (P.T.A.B. Mar. 22, 2016)
Cite Document
IPR2015-00644, No. 1099-2 Exhibit - Declaration of Prof Joel Hay Public Version (P.T.A.B. Mar. 22, 2016)
+ More Snippets